Skip to main content

Table 2 Intra– and postoperative outcomes of matched cohort

From: Sugammadex is associated with shorter hospital length of stay after open lobectomy for lung cancer: a retrospective observational study

Variable Pyridostigmine (n = 127) Sugammadex (n = 127) p value
Surgery time (min) 210.0 (180.0–255.0) 210.0 (180.0–252.0) 0.067
PCA    0.004
 Epidural 110 (86.6) 90 (70.9)  
 Intravenous 17 (13.4) 37 (29.1)  
LOS (days) 12.0 (9.5–16.5) 10.0 (8.0–15.0) 0.005
PACU stay (min) 65.0 (60.0–80.0) 60.0 (55.0–75.0) 0.290
Events in PACU
 Dyspnea 4 (3.1) 3 (2.4) 1.000
 HDI 7 (5.5) 4 (3.1) 0.538
Events in Ward
 Pyrexia 38 (29.9) 28 (22.0) 0.198
 Dyspnea 17 (13.4) 10 (7.9) 0.222
 Air leak > 5 days 27 (21.3) 26 (20.5) 1.000
 Atelectasis 38 (29.9) 23 (18.1) 0.040
 Pneumonia 9 (7.1) 6 (4.7) 0.594
 MV 3 (2.4) 2 (1.6) 1.000
 HDI 7 (5.5) 1 (0.8) 0.072
 ICU 5 (3.9) 2 (1.6) 0.443
  1. Data are presented as n (%), median (interquartile range)
  2. PCA Patient controlled analgesia, LOS Length of stay, PACU Post anesthesia care unit, HDI Hemodynamic instability, MV Mechanical ventilator use, ICU Intensive care unit admission